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Introduction 
The seventh principle of the NICE guidance on medicines optimisation focuses on computerised clinical 
decision support as a means to improving medication safety at the point of prescribing.1 The PRACtICe study 
conducted in England showed that medication errors occurred for one in eight patients and involved one in 20 
prescriptions items, with one severe error in 550 prescription items.2 The complexities of the prescribing 
process and the multi-factorial nature of iatrogenic harms mean that a single approach to prescribing safety is 
insufficient. Clinical decision support (CDS) embedded in general practice (GP) computers have shown great 
potential in facilitating safe prescribing by performing background safety checks and providing clinical advice 
and alerts to prescribers.3  A number of definitions exist for CDS.  In this article, we define a clinical decision 
support system as software designed and embedded in GP computers that provides intelligently-filtered, 
evidence-adaptive knowledge or person-specific information, to directly support clinical decision-making at 
the point of prescribing medicines. 
 
Key themes in the NICE guidance 
The NICE guidance highlights some challenging aspects of designing and developing effective clinical decision 
support systems (CDSS). However, it did not specify how computerised CDSS should be designed or 
implemented, to encourage innovation and solutions that are fit for purpose. A summary of the 
recommendations and the implications for general practice is presented in Table 1.  
Table 1 Summary of the NICE guidance on computerised clinical decision support in primary care 
Summary of recommendations Implications for practice 
Organisations are encouraged to use 
CDSS taking into account existing 
systems and resource implications to 
support  clinical decision-making and 
prescribing, but ensure that these do not 
replace clinical judgment  
Organisations should provide CDSS 
Clinicians should use the CDSS provided but remember that 
their clinical judgement supersedes any advice that may be 
offered by such systems. 
Organisations should ensure that robust 
and transparent processes are in place 
for developing, using, reviewing and 
updating computerised CDSS. 
Organisations should ensure that the system is up to date and 
provide facility for giving feedback about the performance of 
the system to facilitate further improvement. 
Clinicians should avoid creating work-arounds because these 
can cause errors.  
Organisations are to ensure that 
clinicians using CDSS at the point of 
prescribing have the required knowledge 
and skills, including an understanding of 
its limitations.4 
Clinicians need to make sure that they have the necessary 
knowledge and skills to use CDSS effectively, including 
knowing the capabilities of the CDSS at their disposal. 
They also need to identify their own development and training 
needs to help them and their  organisations meet prescribing 
safety goals 
CDSS for clinical decision making and 
prescribing support, should: 
 Identify important safety issues 
 provide facility for health 
professionals to acknowledge 
mandatory alerts and this should 
not be customisable for alerts 
relating to medicines-related 'never 
events' 
 reflect the best available evidence 
and is up‑to‑date 
Clinicians should not turn off mandatory alerts. Rather, they 
should review and action or acknowledge such alerts.  
Clinicians should review and reflect on how they use CDSS in 
practice and whether this is at a level  that continually 
optimises prescribing 
 
 contains useful clinical information 
that is relevant to the health 
professional to reduce 'alert fatigue'  
 
Recommendations for optimal use of CDSS: how might your prescribing practice be affected? 
 Ensure you have correctly recorded all necessary patient information, such as date of birth, weight and 
allergy status in the GP computer system. This will ensure that the safety alerts generated by the GP 
computer system reflect patient specific information. If you have decided after careful evaluation that the 
benefits of prescribing a medicine singly or in combination with other medicines outweigh the risks and 
elect to override an alert, then this should be clearly documented in the patient record and highlighted on 
the prescription.5  
 Give specific instructions when prescribing. For example, instructions such as, ‘as directed,’ ‘as required’ 
or ‘prn’ are not useful if the dose of a medicine is required in tailoring clinical advice and alerts.  
 One of the key priorities of the NICE guidance is implementing a ‘system for identifying, reporting and 
learning from medicines-related patient safety incidents’.  CDSS can help with identifying patients who 
may have been subject to medication errors or adverse drug events in the past so that on subsequent 
visits, clinicians are warned to avoid any potential error or harm. 
 Adopt a culture of safety and encourage appropriate safety behaviour devoid of fear of being disciplined 
unnecessarily. Evidence suggests that prescribers override alerts even when few false positive alerts are 
displayed.6 Avoid ignoring alerts without review and remember to flag false, inappropriate, or unnecessary 
alerts you come across to other clinicians and system developers.  
 Provide regular evaluation and feedback on the performance of GP computer systems including the 
integrated CDS, to help inform current and future development.   Collaboration with CDS creators and 
system vendors will help optimise the design and effectiveness of CDSS. 
 Be aware of how the CDSS alert information is updated. Any new information should be clearly and easily 
identifiable by users to ensure they do not miss important information.  
 
Opportunities for further improvements  
The NICE guidance presents a good opportunity to address recurrent and difficult problems associated with 
safety alerts generated by CDS in GP computer systems. The results of a previous questionnaire survey of 
general practitioners from six English primary care trusts regarding the safety features of GP computer systems 
showed that many were unsure as to whether the system they were using had some of the safety features 
specified in the survey. Additionally, some of the respondents incorrectly believed that their clinical computer 
systems would warn them about potential hazardous situations, such as contraindications, abnormal doses 
and frequencies and only a few of the respondents said they had received formal training on how to use the 
safety features in their GP computer system.7 Although the study needs to be updated in light of current 
practice, it is a window into some of the key prescribing and medication safety problems facing clinicians in 
practice. 
 
The guidance could be extended to provide clear recommendations and specify responsibilities for managing 
patients who may have shared care arrangements. 
 
Conclusion  
CDSS are useful tools for making clinical and prescribing decisions, and can optimise medicines use. The risks 
associated with prescribing and use of CDSS must be recognised, managed and controlled ideally by adopting a 
human factors approach. Regular review and feedback on the effectiveness of features and functionalities of 
CDSS are essential for accurate, consistent and quality clinical decision-making and prescribing medicines 
safely. 
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